Merrick Medical Center
Merrick Medical Center was paid $954K by Medicaid between Jan 2018 and Nov 2024, across 50 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 12% of everything it billed.
CENTRAL CITY, NE 68826
Next to other Critical Access Hospital providers in Nebraska
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,720 | $98K | |
| 2019 | 3,222 | $79K | |
| 2020 | 3,954 | $105K | |
| 2021 | 8,537 | $347K | |
| 2022 | 5,322 | $262K | |
| 2023 | 1,183 | $54K | |
| 2024incomplete | 426 | $9K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 12% | 1,500 | 378 | $118K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 661 | 536 | $98K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.9% | 4,437 | 3,218 | $94K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 9.5% | 2,023 | 1,285 | $91K |
| 80053 | Comprehensive metabolic panel | 9.3% | 2,390 | 2,095 | $88K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.8% | 384 | 306 | $84K |
| 36415 | Collection of venous blood by venipuncture | 5.5% | 5,259 | 3,909 | $52K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.4% | 179 | 148 | $52K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.7% | 1,428 | 1,188 | $45K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.0% | 210 | 152 | $29K |
| 80061 | Lipid panel | 2.1% | 714 | 691 | $20K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.9% | 200 | 165 | $18K |
38 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | 1.8% | 904 | $17K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.6% | 911 | $16K |
| 80050 | General health panel | 1.5% | 85 | $15K |
| 84439 | 1.3% | 467 | $12K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.3% | 619 | $12K |
| 81001 | 1.2% | 739 | $11K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 215 | $11K |
| 83605 | 1.0% | 288 | $10K | |
| J3490 | Unclassified drugs | <1% | 994 | $9K |
| 84145 | <1% | 158 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 170 | $7K |
| 86140 | <1% | 129 | $4K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 309 | $4K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 71 | $4K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 62 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 49 | $3K |
| 84484 | <1% | 97 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 96 | $2K |
| 82607 | <1% | 44 | $2K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 15 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 20 | $1K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $1K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 24 | $1K |
| 83880 | <1% | 16 | $1K | |
| 83735 | <1% | 40 | $1K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 17 | $870.00 |
| 97161 | <1% | 17 | $786.21 | |
| 85027 | <1% | 56 | $696.98 | |
| 85610 | <1% | 92 | $557.41 | |
| 82043 | <1% | 20 | $551.29 | |
| 87077 | <1% | 13 | $511.99 | |
| 82570 | <1% | 20 | $355.30 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 130 | $354.91 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 20 | $341.60 |
| 85652 | <1% | 18 | $301.85 | |
| 81003 | <1% | 15 | $150.22 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 14 | $0.00 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Merrick Medical Center | Central City, NE | $1.25M |
| Merrick Medical Center | Fullerton, NE | $45K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.